The Advancements in mAbs Technology - Ahmed, Manal Mohamed Elsayed
44,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
22 °P sammeln
  • Broschiertes Buch

Biopharmaceuticals are innovative solutions that have revolutionized the treatment of important chronic diseases and malignancies. Monoclonal antibodies (mAbs) are one of important biopharmaceuticals. They are a group of antibodies produced by identical clones of B lymphocytes against a particular antigen. mAbs are identical in several properties. These characteristics of mAbs highlight their differences with the polyclonal antibodies which have heterogenous activities and recognize different epitopes on an antigen. This book will update readers on several cutting-edge aspects of mAbs…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Biopharmaceuticals are innovative solutions that have revolutionized the treatment of important chronic diseases and malignancies. Monoclonal antibodies (mAbs) are one of important biopharmaceuticals. They are a group of antibodies produced by identical clones of B lymphocytes against a particular antigen. mAbs are identical in several properties. These characteristics of mAbs highlight their differences with the polyclonal antibodies which have heterogenous activities and recognize different epitopes on an antigen. This book will update readers on several cutting-edge aspects of mAbs Technology with valuable update information for Immunologist, microbiologist, pharmacologist, oncologist and toxicologist, who may be interested to understanding of the impact significance and recent advances in the field of mAbs Technology with a focus on the production processes of mAbs, their important diagnostic and therapeutic applications and the exploring of patent and scientific mapping of mAbs.
Autorenporträt
Manal M. E. Ahmed is Immunologist, Researcher, Columnist, Author, Reviewer, Editorial Board Member, Public Speaker, Consultant and Principal Investigator in Egypt. She successfully completed PhD degree and worked over almost 25 years in innovating novel biological products for pharmaceutical and diagnostic industries.